T1	SNP 29 37	variants
T2	Association 14 28	susceptibility
E1	Association:T2 bc:T3 snp_int:T1
T3	Cancer 0 13	Breast cancer
T4	Entity 102 107;77 86	women norwegian
R1	Population_assignment Arg1:T1 Arg2:T4	
T5	Entity 87 101	postmenopausal
R2	Risk_Factor Arg1:T1 Arg2:T5	
T6	Cell_types_tissues_affected 42 62	mammographic density
E2	Cell_types_tissues_affected:T6 Agent:T1
T7	Spec 293 305	hypothesized
T8	Association 325 339	susceptibility
E3	Association:T8 bc:T9 snp_int:T10
T9	Cancer 311 324	breast cancer
T10	SNP 340 348	variants
T11	Organic_inorganic_molecules_affected 360 362	MD
E4	Organic_inorganic_molecules_affected:T11 Agent:T10
R4	Equiv Arg1:E4 Arg2:E2	
T12	Entity 406 424	nongenetic factors
R5	Risk_Factor Arg1:T10 Arg2:T12	
T13	Spec 387 390	may
R6	Speculation_marker Arg1:T12 Arg2:T13	
R3	Speculation_marker Arg1:E4 Arg2:T7	
T14	Spec 671 680	determine
T15	Cell_types_tissues_affected 718 720	MD
E5	Cell_types_tissues_affected:T15 Agent:T16
T16	SNP 705 713	each SNP
R7	Member Arg1:T10 Arg2:T16	
R8	Speculation_marker Arg1:E5 Arg2:T14	
T17	SNP 809 811;838 842	17 SNPs
T18	Cancer 824 837	breast cancer
T19	Cell_types_tissues_affected 788 790	MD
E6	Cell_types_tissues_affected:T19 Agent:T17 Agent2:T23
T20	Association 791 803	associations
E7	Association:T20 snp_int:T17 bc:T18 snp_int2:T23
T21	Entity 878 897	non-genetic factors
T22	Spec 778 787	evaluated
R9	Speculation_marker Arg1:E6 Arg2:T22	
T23	SNP 809 811;838 842	17 SNPs
R10	Risk_Factor Arg1:T23 Arg2:T21	
T24	Entity 913 919	6q25.1
T25	SNP 920 929	rs9383938
T26	Entity 934 940	TXNRD2
T27	SNP 941 950	rs8141691
R11	SNP_coupled_gene Arg1:T27 Arg2:T26	
R12	SNP_location Arg1:T25 Arg2:T24	
T28	Level 957 984	statistically significantly
T29	Cell_types_tissues_affected 1001 1011	percent MD
E8	Cell_types_tissues_affected:T29 Agent:T27 Agent2:T25
A1	Level E8 High
R13	Level_marker Arg1:E8 Arg2:T28	
T30	Entity 1057 1063	6q25.1
T31	SNP 1064 1073	rs9383938
R14	SNP_location Arg1:T31 Arg2:T30	
T32	Association 1116 1122	effect
E9	Association:T32 bc:T33 snp_int:T31
T33	Cancer 1126 1139	breast cancer
T34	Entity 1160 1166	6q25.1
T35	SNP 1167 1176	rs3734805
R15	SNP_location Arg1:T35 Arg2:T34	
T36	Cell_types_tissues_affected 1180 1190	percent MD
E10	Cell_types_tissues_affected:T36 Agent:T35 Agent2:T41 Agent3:T44
T37	Entity 1206 1212	parous
T38	Entity 1217 1228	nulliparous
T39	Entity 1229 1234	women
R16	Risk_Factor Arg1:T35 Arg2:T37	
R17	Risk_Factor Arg1:T35 Arg2:T38	
R18	Risk_Factor Arg1:T35 Arg2:T39	
T40	Entity 1281 1287	9q31.2
T41	SNP 1288 1296	rs865686
T42	Entity 1301 1307	MRPS30
T43	Entity 1308 1313	FGF10
T44	SNP 1314 1323	rs4415084
R19	SNP_location Arg1:T44 Arg2:T43	
R20	SNP_location Arg1:T44 Arg2:T42	
R21	SNP_location Arg1:T41 Arg2:T40	
T45	Entity 1350 1353	BMI
R22	Risk_Factor Arg1:T44 Arg2:T45	
R23	Risk_Factor Arg1:T41 Arg2:T45	
T46	Neg 1411 1413	no
T47	Spec 1414 1422	evidence
T48	Entity 1449 1457;1472 1479	estrogen therapy
T49	Entity 1462 1479	progestin therapy
T50	Entity 1487 1506	alcohol consumption
R28	Member Arg1:T17 Arg2:T25	
R29	Member Arg1:T17 Arg2:T27	
R30	Equiv Arg1:T25 Arg2:T31	
R31	Member Arg1:T23 Arg2:T35	
R32	Member Arg1:T23 Arg2:T41	
R33	Member Arg1:T23 Arg2:T44	
T51	Cell_types_tissues_affected 1426 1445	effect modification
E11	Cell_types_tissues_affected:T51 Agent:T23
R34	Equiv Arg1:E11 Arg2:E6	
R35	Negation_marker Arg1:T48 Arg2:T46	
R36	Negation_marker Arg1:T49 Arg2:T46	
R37	Negation_marker Arg1:T50 Arg2:T46	
R38	Speculation_marker Arg1:T50 Arg2:T47	
R39	Speculation_marker Arg1:T48 Arg2:T47	
R40	Speculation_marker Arg1:T49 Arg2:T47	
T52	Spec 1534 1542	evidence
T53	Cell_types_tissues_affected 1582 1584	MD
E12	Cell_types_tissues_affected:T53 Agent:T55 Agent2:T59
T54	Cancer 1589 1602	breast cancer
T55	SNP 1553 1573	genetic risk factors
R41	Speculation_marker Arg1:E12 Arg2:T52	
T56	Association 1585 1588	and
E13	Association:T56 bc:T54 snp_int:T55 snp_int2:T59
T57	Spec 1610 1618	possible
T58	Entity 1630 1656	environmental interactions
R42	Speculation_marker Arg1:T58 Arg2:T57	
T59	SNP 1622 1629	genetic
R43	Risk_Factor Arg1:T59 Arg2:T58	
R44	Member Arg1:T1 Arg2:T23	
R45	Member Arg1:T1 Arg2:T17	
